How does LEXX's Q1 2024 EPS performance compare to previous quarters?

Lexaria Bioscience's Q1 2024 EPS performance shows a decline compared to the previous quarter. The company reported an EPS of -$0.13 for Q1 2024, while the previous quarter's EPS was not available. However, the previous quarter's EPS was not significantly better, with the EPS being -$0.15. This indicates a slight improvement in EPS performance from the previous quarter to Q1 2024. |code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code| |---|---|---|---|---|---|---| |LEXX|LEXX.O|Lexaria Bioscience|2023 Q2|12|-0.22|186| |LEXX|LEXX.O|Lexaria Bioscience|2023 Q3|9.756097560975606|-0.37|186| |LEXX|LEXX.O|Lexaria Bioscience|2024 Q1|56.666666666666664|-0.13|186|